Institution: | (1) Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bldg. 35, Rm. 1C912, 35 Convent Drive, Bethesda, MD, USA;(2) Mood and Anxiety Disorders Program, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, MSC-1026, Bldg. 10, Rm. B1D43, Bethesda, MD, USA;(3) Johnson and Johnson Pharmaceutical Research and Development, 1125 Trenton-Harbourton Road, E32000 Titusville, NJ, USA |